Clinical trial No longer in our active list Phase 3 Interventional Ages 18 to 99

Testing maridebart cafraglutide for weight loss in adults with type 2 diabetes and obesity

Official title: A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight (MARITIME-2)

Run by Amgen · NCT06858878 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study tests whether a new weight loss medication called maridebart cafraglutide can help adults with type 2 diabetes and obesity lose weight better than a placebo.

Research outlook What's coming for Type 2 diabetes: the next 6 months to 5 years

Quick facts

PhasePhase 3
Study typeInterventional
Ages18 Years to 99 Years
SexAll
Enrollment999 (estimated)
SponsorAmgen
Industry-sponsored
Locations83 sites (Mobile, Alabama and 82 other locations)
Trial IDNCT06858878 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and older with a body mass index of 27 kg/m² or higher and a diagnosis of type 2 diabetes.

Probably not a fit

Patients with type 1 diabetes, significant recent weight changes, or certain serious health conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the efficacy and safety of maridebart cafraglutide in adults with type 2 diabetes mellitus who are overweight or obese. Participants will receive either the medication or a placebo to assess the change in body weight over the course of the study. The trial aims to demonstrate that maridebart cafraglutide is more effective than placebo in promoting weight loss among this population. The study is designed for individuals who have previously struggled with weight loss through diet and exercise.

Why it matters

Potential benefit: If successful, this treatment could provide a new option for weight management in patients with type 2 diabetes, potentially improving their overall health and diabetes control.

How similar studies have gone: Other studies have shown promising results with similar weight loss medications in patients with type 2 diabetes, indicating potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 18 years.
* Body mass index ≥ 27 kg/m\^2.
* History of at least 1 self-reported unsuccessful attempt at weight loss by diet and exercise.
* Diagnosis of T2DM.

Exclusion Criteria:

* Type 1 diabetes mellitus.
* Self-reported change in body weight \> 5 kg within 90 days before screening.
* Proliferative diabetic retinopathy OR diabetic macular edema OR non-proliferative diabetic retinopathy that requires acute treatment.
* Obesity induced by other endocrinologic disorders.
* Family (first-degree relative\[s\]) or personal history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2.
* History of chronic pancreatitis or history of acute pancreatitis within 180 days before screening.
* History of unstable major depressive disorder (MDD) or other severe psychiatric disorder within 2 years before screening.
* Lifetime history of suicide attempt.

Where it's running

  • Alliance for Multispecialty Research Mobile
    Mobile, Alabama, United States
    Recruiting
  • Gilbert Center for Family Medicine
    Gilbert, Arizona, United States
    Recruiting
  • Desert Clinical Research
    Mesa, Arizona, United States
    Recruiting
  • Avacare Foothills Research Center
    Phoenix, Arizona, United States
    Recruiting
  • San Fernando Valley Health Institute
    Canoga Park, California, United States
    Recruiting
  • Core Healthcare Group
    Cerritos, California, United States
    Recruiting
Show 44 more locations
  • Velocity Clinical Research Chula Vista
    Chula Vista, California, United States
    Recruiting
  • Headlands Research California
    Escondido, California, United States
    Recruiting
  • Paradigm Clinical Research
    Modesto, California, United States
    Recruiting
  • Flourish Research
    Northridge, California, United States
    Recruiting
  • University of California Irvine
    Orange, California, United States
    Recruiting
  • Empire Clinical Research
    Pomona, California, United States
    Recruiting
  • Infinity Clinical Trials
    San Diego, California, United States
    Recruiting
  • Greenwich Clinical Trials
    Riverside, Connecticut, United States
    Recruiting
  • Indago Research and Health Center
    Hialeah, Florida, United States
    Recruiting
  • San Marcus Research Clinic Inc
    Miami Lakes, Florida, United States
    Recruiting
  • Optimus U Corporation
    Miami, Florida, United States
    Recruiting
  • New Horizon Research Center
    Miami, Florida, United States
    Recruiting
  • Florida Institute for Clinical Research
    Orlando, Florida, United States
    Recruiting
  • Encore Medical Research of Weston LLC
    Weston, Florida, United States
    Recruiting
  • Conquest Research - Winter Park
    Winter Park, Florida, United States
    Recruiting
  • Alliance For Multispecialty Research - Oak Brook
    Oak Brook, Illinois, United States
    Recruiting
  • Alliance for Multispecialty Research, LLC - Park Ridge
    Park Ridge, Illinois, United States
    Recruiting
  • Endeavor Health Medical Group - Endocrinology and Diabetes- Skokie
    Skokie, Illinois, United States
    Recruiting
  • Indiana Medical Research Institute
    Merrillville, Indiana, United States
    Recruiting
  • Iowa Diabetes Research
    West Des Moines, Iowa, United States
    Recruiting
  • Alliance for Multispecialty Research Newton
    Newton, Kansas, United States
    Recruiting
  • Alliance for Multispecialty Research LLC
    Wichita, Kansas, United States
    Recruiting
  • Advanced Internal Medicine
    Paducah, Kentucky, United States
    Recruiting
  • Ima Clinical Research- Monroe
    Monroe, Louisiana, United States
    Recruiting
  • Annapolis Internal Medicine, LLC
    Annapolis, Maryland, United States
    Recruiting
  • Brigham and Womens Hospital
    Boston, Massachusetts, United States
    Recruiting
  • International Diabetes Center - HealthPartners Institute
    Minneapolis, Minnesota, United States
    Recruiting
  • Alliance for Multispecialty Research - Kansas City
    Kansas City, Missouri, United States
    Recruiting
  • Palm Research Center Inc
    Las Vegas, Nevada, United States
    Recruiting
  • Vector Clinical Trials
    Sparks, Nevada, United States
    Recruiting
  • Premier Research
    Trenton, New Jersey, United States
    Recruiting
  • Albany Medical College
    Albany, New York, United States
    Recruiting
  • Asheville Clinical Research
    Asheville, North Carolina, United States
    Recruiting
  • Physicians East
    Greenville, North Carolina, United States
    Recruiting
  • Carteret Medical Group
    Morehead City, North Carolina, United States
    Recruiting
  • West Clinical Research
    Morehead City, North Carolina, United States
    Recruiting
  • Velocity Clinical Research - Cincinnati
    Blue Ash, Ohio, United States
    Recruiting
  • Velocity Clinical Research - Springdale
    Cincinnati, Ohio, United States
    Recruiting
  • Velocity Clinical Research - Providence
    East Greenwich, Rhode Island, United States
    Recruiting
  • Medical Care LLC
    Elizabethton, Tennessee, United States
    Recruiting
  • Elligo Clinical Research Center
    Austin, Texas, United States
    Recruiting
  • Osvaldo A Brusco MD PA
    Corpus Christi, Texas, United States
    Recruiting
  • Cedar Health Research, LLC
    Dallas, Texas, United States
    Recruiting
  • Soma Clinical Trials, LLC
    Denison, Texas, United States
    Recruiting

+33 more sites. See ClinicalTrials.gov for the full list.

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • TQF3250 capsules for adults with type 2 diabetes and overweight/obesity

    A small, early-phase study will test the safety and how the body handles different doses of TQF3250 pills in adults with type 2 diabetes who are overweight or obese.

    Recruiting Phase 1 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Fuzhou, Fujian and 11 other locations · NCT07747857

  • Lifestyle change program to help type 2 diabetes go into remission in Pakistan

    This study tests whether a structured, plant-predominant lifestyle program can put adults with type 2 diabetes in Lahore, Pakistan into remission for the first six months.

    Recruiting at 2 sites Green International University · Lahore, Punjab Province and 1 other locations · NCT07912944

  • Colchicine for preventing cardiovascular disease in adults with type 2 diabetes

    A 24-week study will test whether low-dose colchicine can help protect blood vessels in adults with type 2 diabetes who have not yet developed artery disease, compared with a placebo.

    Recruiting Phase 2 Tan Tock Seng Hospital · Singapore, Singapore · NCT07837934

  • MWN105 injection in overweight or obese adults you may join

    This early-phase trial tests whether MWN105 is safe and tolerable in overweight or obese adults in China, using a placebo comparison.

    Recruiting Phase 1 Shanghai Minwei Biotechnology Co., Ltd · Kunming, Yunnan · NCT07803809

  • MWN109 tablets in adults with type 2 diabetes mellitus

    A phase 2 trial tests MWN109 tablets versus placebo (and against active control semaglutide) to see if the medicine helps adults with type 2 diabetes lower their blood sugar.

    Recruiting Phase 2 Shanghai Minwei Biotechnology Co., Ltd · Beijing, Beijing Municipality · NCT07801820

  • Brain-heart axis in adults with type 2 diabetes

    This study tests how brain activity and heart regulation relate to metabolic status in adults with type 2 diabetes to understand cognitive and functional health.

    Recruiting Hacettepe University · Tunceli · NCT07757308

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-16 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.